Thinking about the call and all the moving parts, I believe we will not be bought out but will partner. The board has brought in all these high powered and credentialed members including the advisory board. Now a highly respected CEO. This was done in my opinion to seek partnerships and turn this into Pharmaceutical company with the platform drug LL. It doesn't make sense to do this just to sell the company. SK telegraphing a potential suiter with GSK was very interesting and may stir the market with optimizing.